Forschungsmaterial

Mouse models for haematopoiesis and deafness - Mutations in the Growth Factor Independence 1b

Ref.-Nr. 3947 2960 2961 2962

Keywords: SNAG, zinc finger proteins, expression repressors, inner ear development, deafness, hematopoiesis, Green Fluorescence Protein (GFP) as reporter protein

Growth Factor Independence 1b (Gfi1b) is a paralog of Gfi1, sharing nearly identical sequences across their respective protein domains. Gfi1b functions as a transcriptional repressor and is expressed in both the hematopoietic and nervous systems. Its loss of function results in significant defects in hematopoiesis and inner ear development. The two mutant mouse models Gfi1b and P2A are available for licensing and offer unique opportunities for research and therapeutic development.

Gfi1b Knock-In Mouse Model:
This model demonstrates that Gfi1b can effectively substitute for Gfi1 in hematopoiesis, restoring pre-T cell and neutrophil development. Compared to Gfi1 knockouts, these mice exhibit a milder phenotype, enabling in-depth studies of hematopoietic differentiation without severe systemic effects. This model is particularly suited for research focusing on erythroid and megakaryocytic lineages, where Gfi1b is a key regulator.

P2A Point Mutant Mouse Model:
This model highlights the essential role of the SNAG domain in Gfi1’s transcriptional repressor function. The loss of SNAG domain activity replicates the Gfi1 null phenotype, providing a valuable platform for investigating transcriptional regulation and diseases associated with SNAG domain mutations. It is particularly indispensable for studying defects in granulocyte development and inner ear hair cell biology, in particular deafness.

Gfi1 wt GFP and Gfi1b GFP Mouse Models:
There is also a wildtype Gfi1 mouse with a GFP (Green Fluorescence Protein) reporter gene available (Ref. No. 2961) and a Gfi1b mouse with the same GFP reporter gene (Ref. No. 2962).

Vorteile

  • in vivo models with significant defects of inner ear development and hematopoiesis
  • study deafness
  • develop new approaches to treat deafness
  • study immunological disorders

Kommerzielle Anwendung

Researchers and pharmaceutical companies can leverage these models for studying genetic diseases, developing targeted therapies, and advancing hematological and sensory disorder treatments. 

Technologie-Reifegrad

1 2 3 4 5 6 7 8 9
Qualifiziertes System mit Nachweis des erfolgreichen Einsatzes

Relevante Veröffentlichungen

Fiolka, K., et al. (2006) Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development. EMBO Reports 7(3): 326-33. 

Möröy, T. (2005) The zinc finger transcription factor Growth factor independence 1 (Gfi1). Int. J. Biochem. Cell Biol. 37: 541-6.

Wallis, D., et al. (2003) The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival. Development. 130: 221-32.

Saleque, S. et al. (2002) The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 16: 301-6.

An invention from the University of Duisburg-Essen.


Dipl.-Biol. Kordula Kruber

kk@provendis.info
+49 208 9410530